Lobbying client
ANTHEIA
Science and technology company developing next generation plant-inspired medicines
Filings
25
Filed by
1
Reported in-house
—
Reported by firms
$1,080,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2026
Filings
25 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2026
|
INVARIANT LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2026
|
INVARIANT LLC | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2025
|
INVARIANT LLC | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2025
|
INVARIANT LLC | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2025
|
INVARIANT LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2025
|
INVARIANT LLC | — reported |
|
4th Quarter - Report 4th Quarter 2024
|
INVARIANT LLC | $60,000 reported |
|
3rd Quarter - Report 3rd Quarter 2024
|
INVARIANT LLC | $60,000 reported |
|
2nd Quarter - Report 2nd Quarter 2024
|
INVARIANT LLC | $60,000 reported |
|
1st Quarter - Report 1st Quarter 2024
|
INVARIANT LLC | $60,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| INVARIANT LLC | 24 | $1,080,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 19 |
| Defense | DEF | 10 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 1260 | 117th | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.